Literature DB >> 15890923

Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.

Nicole A Patterson1, Jessica L Smith, Michelle A Ozbun.   

Abstract

Oncogenic human papillomaviruses (HPVs) are difficult to study experimentally as they replicate at low levels in vivo. This has precluded the purification of high-risk HPV virions from in vivo lesions. Virus-like particles (VLPs) and pseudovirions from low- and high-risk HPV types can emulate various aspects of HPV virion attachment and infections. These studies suggest that HPV infection is mediated by alpha6-integrin and/or heparan-sulfonated receptors. However, whether VLPs and pseudovirions accurately reflect the infection process of HPV virions has not been verified. We generated infectious HPV31b virions from organotypic (raft) tissues and performed experimental infections in a variety of cells. Successful infection following viral attachment, internalization, and nuclear transport was assayed by detecting newly synthesized, spliced HPV transcripts using reverse transcription (RT)-PCR or RT-quantitative PCR. Most human epithelial cells were infected with HPV31b at a multiplicity of infection as low as 1 to 10 viral genome equivalents per cell. HPV31b infection was detected in other cell lines, including COS-7 monkey kidney cells, but higher viral multiplicities of infection were required. Heparin preparations of various molecular weights or heparinase I treatment of cells prevented HPV31b infection of COS-7 cells and C-33A human cervical cancer cells in reproducible and dose-dependent manners. However, these reagents were unable to block infection of human keratinocytes, including HaCaT and N/TERT-1 cells and low-passage human foreskin keratinocytes. These data suggest that HPV31b infection of human keratinocytes, the natural host cell for HPV infections in vivo, does not require a heparan-sulfonated receptor, whereas heparan sulfate is important for infection of some other cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890923      PMCID: PMC1112118          DOI: 10.1128/JVI.79.11.6838-6847.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Human papillomavirus infection requires cell surface heparan sulfate.

Authors:  T Giroglou; L Florin; F Schäfer; R E Streeck; M Sapp
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4.

Authors:  G Sibbet; C Romero-Graillet; G Meneguzzi; M S Campo
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

3.  Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.

Authors:  A L Combita; A Touzé; L Bousarghin; P Y Sizaret; N Muñoz; P Coursaget
Journal:  FEMS Microbiol Lett       Date:  2001-10-16       Impact factor: 2.742

4.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

Review 5.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

6.  Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids.

Authors:  N Krauzewicz; J Stokrová; C Jenkins; M Elliott; C F Higgins; B E Griffin
Journal:  Gene Ther       Date:  2000-12       Impact factor: 5.250

Review 7.  Human papillomavirus life cycle: active and latent phases.

Authors:  F Stubenrauch; L A Laimins
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

8.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP.

Authors:  C S Yoon; K D Kim; S N Park; S W Cheong
Journal:  Biochem Biophys Res Commun       Date:  2001-05-11       Impact factor: 3.575

10.  Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate.

Authors:  N D Christensen; C A Reed; T D Culp; P L Hermonat; M K Howett; R A Anderson; L J Zaneveld
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

View more
  42 in total

1.  Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.

Authors:  Timothy D Culp; Lynn R Budgeon; M Peter Marinkovich; Guerrino Meneguzzi; Neil D Christensen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Herpes Simplex Virus 1 Enters Human Keratinocytes by a Nectin-1-Dependent, Rapid Plasma Membrane Fusion Pathway That Functions at Low Temperature.

Authors:  Charlotte L Sayers; Gillian Elliott
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.

Authors:  Hao-Shun Huang; Paul F Lambert
Journal:  Virology       Date:  2012-09-18       Impact factor: 3.616

Review 4.  Principles of polyoma- and papillomavirus uncoating.

Authors:  Carla Cerqueira; Mario Schelhaas
Journal:  Med Microbiol Immunol       Date:  2012-09-23       Impact factor: 3.402

Review 5.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

6.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 7.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

8.  Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.

Authors:  Jessica L Smith; Samuel K Campos; Angela Wandinger-Ness; Michelle A Ozbun
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

Review 10.  Cellular receptor binding and entry of human papillomavirus.

Authors:  Tan Letian; Zhang Tianyu
Journal:  Virol J       Date:  2010-01-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.